Reversible lesion of the corpus callosum associated with COVID-19: A case report
dc.contributor.author | Gemici Y.I. | |
dc.contributor.author | Tasci I. | |
dc.date.accessioned | 2024-07-22T08:06:22Z | |
dc.date.available | 2024-07-22T08:06:22Z | |
dc.date.issued | 2021 | |
dc.description.abstract | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may affect the central nervous system and peripheral nervous system. Major central nervous system manifestations of SARS-CoV-2 infection include seizures, meningoencephalitis, ischemic stroke, anosmia, and hypogeusia. The reversible splenial lesion syndrome was first described in 2004. Although reversible splenial lesion syndrome was initially recognized as a benign phenomenon, a second type of reversible splenial lesion syndrome was identified in later years, which has a poorer prognosis and potentially serious sequela. Reversible splenial lesion syndrome can be caused by numerous etiologies including viruses. In this report, we present a rare case of COVID-19 with reversible splenial lesion, who presented with ataxia and dizziness. © 2021, ASEAN Neurological Association. All rights reserved. | |
dc.identifier.DOI-ID | 10.54029/2021VMW | |
dc.identifier.issn | 18236138 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/13474 | |
dc.language.iso | English | |
dc.publisher | ASEAN Neurological Association | |
dc.rights | All Open Access; Bronze Open Access | |
dc.subject | azithromycin | |
dc.subject | C reactive protein | |
dc.subject | favipiravir | |
dc.subject | hydroxychloroquine sulfate | |
dc.subject | lactate dehydrogenase | |
dc.subject | oseltamivir | |
dc.subject | adult | |
dc.subject | Article | |
dc.subject | ataxia | |
dc.subject | brain disease | |
dc.subject | case report | |
dc.subject | clinical article | |
dc.subject | computer assisted tomography | |
dc.subject | coronavirus disease 2019 | |
dc.subject | corpus callosum | |
dc.subject | dizziness | |
dc.subject | Doppler ultrasonography | |
dc.subject | electrocardiography | |
dc.subject | encephalitis | |
dc.subject | follow up | |
dc.subject | ground glass opacity | |
dc.subject | human | |
dc.subject | lumbar puncture | |
dc.subject | lung consolidation | |
dc.subject | lymphocyte count | |
dc.subject | lymphocytopenia | |
dc.subject | magnetic resonance angiography | |
dc.subject | male | |
dc.subject | middle aged | |
dc.subject | nuclear magnetic resonance imaging | |
dc.subject | polymerase chain reaction | |
dc.subject | reversible splenial lesion syndrome | |
dc.subject | risk factor | |
dc.title | Reversible lesion of the corpus callosum associated with COVID-19: A case report | |
dc.type | Article |